Scholarlink

Background <p>Peptide YY (PYY) plays a key role in postprandial satiety and is markedly increased after Roux-en-Y gastric bypass (RYGB). While GLP-1 has been widely studied, the role of PYY as a predictor of weight loss success remains unclear. Some patients are considered non-responders, achieving &lt; 50% excess BMI loss (EBMIL) or experiencing significant weight regain. This systematic review and meta-analysis aimed to compare fasting PYY levels and postprandial area under the curve (AUC) between RYGB responders and non-responders.</p> Methods <p>Following PRISMA guidelines, PubMed, Embase, and Cochrane databases were searched for observational or interventional studies assessing PYY in adult RYGB patients stratified by weight loss response. Primary outcomes were fasting PYY levels and PYY AUC after standardized meals. Random-effects meta-analysis was conducted using Review Manager 5.4. Mean differences (MD) with 95% confidence intervals (CI) were calculated. Heterogeneity was assessed via Cochran’s Q and I².</p> Results <p>Five studies were included in the systematic review (92 non-responders and 89 responders), contributing to the fasting PYY meta-analysis, which showed no significant difference between groups (MD 1.71 pg/mL; 95% CI − 5.22 to 8.63; I² = 0%). Four studies reported AUC, also showing no difference (MD 53.16 pg·min/mL; 95% CI − 1726.29 to 1832.61; I² = 0%). Several studies observed lower satiety scores and attenuated appetite suppression in non-responders despite similar PYY profiles. No significant genetic variants in PYY or its receptor were associated with weight loss outcomes.</p> Conclusion <p>RYGB responders and non-responders have comparable fasting and postprandial PYY concentrations. These findings suggest that differential weight loss after RYGB is likely mediated by factors beyond PYY secretion, including neural, behavioral, or other hormonal mechanisms.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hormone PYY does not Explain the Variability in Weight Loss After Roux-en-Y Gastric Bypass: Evidence From a Meta-Analysis.

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月19日

查看全文
  • Giovanna Macanhã Scremin,
  • Pedro Bicudo Bregion,
  • Ana Cláudia Portes Nascimento,
  • Júlia Marchiori Fein,
  • Leonardo Halamy Pereira,
  • Victor Kenzo Ivano,
  • Everton Cazzo

摘要

Background

Peptide YY (PYY) plays a key role in postprandial satiety and is markedly increased after Roux-en-Y gastric bypass (RYGB). While GLP-1 has been widely studied, the role of PYY as a predictor of weight loss success remains unclear. Some patients are considered non-responders, achieving < 50% excess BMI loss (EBMIL) or experiencing significant weight regain. This systematic review and meta-analysis aimed to compare fasting PYY levels and postprandial area under the curve (AUC) between RYGB responders and non-responders.

Methods

Following PRISMA guidelines, PubMed, Embase, and Cochrane databases were searched for observational or interventional studies assessing PYY in adult RYGB patients stratified by weight loss response. Primary outcomes were fasting PYY levels and PYY AUC after standardized meals. Random-effects meta-analysis was conducted using Review Manager 5.4. Mean differences (MD) with 95% confidence intervals (CI) were calculated. Heterogeneity was assessed via Cochran’s Q and I².

Results

Five studies were included in the systematic review (92 non-responders and 89 responders), contributing to the fasting PYY meta-analysis, which showed no significant difference between groups (MD 1.71 pg/mL; 95% CI − 5.22 to 8.63; I² = 0%). Four studies reported AUC, also showing no difference (MD 53.16 pg·min/mL; 95% CI − 1726.29 to 1832.61; I² = 0%). Several studies observed lower satiety scores and attenuated appetite suppression in non-responders despite similar PYY profiles. No significant genetic variants in PYY or its receptor were associated with weight loss outcomes.

Conclusion

RYGB responders and non-responders have comparable fasting and postprandial PYY concentrations. These findings suggest that differential weight loss after RYGB is likely mediated by factors beyond PYY secretion, including neural, behavioral, or other hormonal mechanisms.